Oncology
In vivo CAR-T can solve the delivery problem – but solid tum...
A new generation of in vivo CAR-T cell technologies promises to remove some of the biggest practical barriers to conventional cell therapy.
Oncology
Unlocking the scalability of allogeneic CAR-T
Allogeneic CAR-T, built from healthy donor T-cells, offers a different path toward scale, accessibility, and consistency.
R&D
Why every healthcare breakthrough creates a new education ch...
Patients will only benefit from a health breakthrough if HCPs and the systems around them are able to put it into practice.
Sales & Marketing
Sponsored
Commercial Evidence: Turning field intelligence into actiona...
Agentic Call Reports help turn field observations into scalable, actionable insights generating Commercial Evidence.
Digital
Healthcare AI’s off switch needs a budget
An AI system can be cheap to buy and expensive to stop.
Sales & Marketing
Digital
Market Access
Editor's Picks
Editor's Picks
